A detailed history of Phocas Financial Corp. transactions in Johnson & Johnson stock. As of the latest transaction made, Phocas Financial Corp. holds 5,689 shares of JNJ stock, worth $945,227. This represents 3.33% of its overall portfolio holdings.

Number of Shares
5,689
Previous 5,689 -0.0%
Holding current value
$945,227
Previous $900 Million 7.6%
% of portfolio
3.33%
Previous 3.69%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

SELL
$155.22 - $162.74 $883,046 - $925,827
-5,689 Reduced 50.0%
5,689 $900 Million
Q1 2024

Apr 17, 2024

BUY
$155.22 - $162.74 $883,046 - $925,827
5,689 Added 100.0%
11,378 $901 Million
Q4 2023

Jan 29, 2024

BUY
$145.6 - $158.88 $828,318 - $903,868
5,689 New
5,689 $891,000
Q1 2023

Apr 13, 2023

SELL
$151.05 - $180.26 $10,271 - $12,257
-68 Reduced 0.54%
12,478 $1.93 Million
Q4 2022

Jan 10, 2023

SELL
$160.2 - $179.79 $116,144 - $130,347
-725 Reduced 5.46%
12,546 $0
Q3 2022

Oct 14, 2022

BUY
$161.33 - $179.52 $146,003 - $162,465
905 Added 7.32%
13,271 $2.17 Million
Q4 2021

Feb 15, 2022

SELL
$155.93 - $173.01 $100,107 - $111,072
-642 Reduced 4.94%
12,366 $2.12 Million
Q2 2021

Aug 16, 2021

BUY
$159.48 - $171.07 $102,864 - $110,340
645 Added 5.22%
13,008 $2.14 Million
Q1 2021

Jun 22, 2021

SELL
$153.07 - $170.48 $4,592 - $5,114
-30 Reduced 0.24%
12,363 $2.03 Million
Q4 2020

Mar 01, 2021

SELL
$137.11 - $157.38 $17 Billion - $19.5 Billion
-123,921,190 Reduced 99.99%
12,393 $1.95 Million
Q4 2020

Feb 16, 2021

BUY
$137.11 - $157.38 $17 Billion - $19.5 Billion
123,921,396 Added 1016832.69%
123,933,583 $1.95 Million
Q3 2020

Nov 13, 2020

BUY
$140.38 - $153.83 $11,230 - $12,306
80 Added 0.66%
12,187 $1.81 Million
Q2 2020

Aug 24, 2020

SELL
$128.81 - $155.51 $42,507 - $51,318
-330 Reduced 2.65%
12,107 $1.7 Million
Q1 2020

May 15, 2020

SELL
$111.14 - $153.99 $8,891 - $12,319
-80 Reduced 0.64%
12,437 $1.63 Million
Q3 2019

Nov 15, 2019

SELL
$126.95 - $142.14 $15.9 Billion - $17.8 Billion
-125,161,066 Reduced 99.99%
12,517 $1.62 Million
Q2 2019

Aug 16, 2019

BUY
$131.15 - $144.24 $16.4 Billion - $18.1 Billion
125,161,066 Added 999928.62%
125,173,583 $0
Q4 2018

Feb 15, 2019

SELL
$122.84 - $147.84 $19,654 - $23,654
-160 Reduced 1.26%
12,517 $1.62 Million
Q3 2018

Nov 15, 2018

SELL
$121.58 - $142.88 $32,705 - $38,434
-269 Reduced 2.08%
12,677 $1.75 Million
Q2 2018

Aug 31, 2018

SELL
$119.4 - $131.76 $15.5 Billion - $17.1 Billion
-129,450,637 Reduced 99.99%
12,946 $1.57 Million
Q2 2018

Aug 15, 2018

BUY
$119.4 - $131.76 $15.5 Billion - $17.1 Billion
129,450,637 Added 999927.69%
129,463,583 $1.57 Million
Q1 2018

May 17, 2018

SELL
$125.1 - $148.14 $5,629 - $6,666
-45 Reduced 0.35%
12,946 $2,000
Q3 2017

Nov 17, 2017

BUY
$129.47 - $135.38 $1.68 Million - $1.76 Million
12,991
12,991 $2,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $434B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Phocas Financial Corp. Portfolio

Follow Phocas Financial Corp. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Phocas Financial Corp., based on Form 13F filings with the SEC.

News

Stay updated on Phocas Financial Corp. with notifications on news.